Onradivir is an orally active antiviral agent that specifically targets the PB2 subunit of influenza A virus RNA polymerase, exhibiting an IC50 of 0.562 nM. By inhibiting cap binding, Onradivir effectively suppresses viral replication, lowers viral titers, and mitigates influenza A virus infection. In preclinical studies, Onradivir demonstrated enhanced survival rates in mice infected with influenza A virus and significantly reduced viral loads. This compound is valuable for researching influenza A virus infections and developing potential therapeutic strategies.
Onradivir is an orally active antiviral agent that specifically targets the PB2 subunit of influenza A virus RNA polymerase, exhibiting an IC50 of 0.562 nM. By inhibiting cap binding, Onradivir effectively suppresses viral replication, lowers viral titers, and mitigates influenza A virus infection. In preclinical studies, Onradivir demonstrated enhanced survival rates in mice infected with influenza A virus and significantly reduced viral loads. This compound is valuable for researching influenza A virus infections and developing potential therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
